Cargando…

An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey

BACKGROUND: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial has been the largest study ever conducted among patients in Turkey regarding aspirin treatment. In the subgroup analysis of the hypertensive group of the Appropriateness of Aspirin Use in...

Descripción completa

Detalles Bibliográficos
Autores principales: Memiç Sancar, Kadriye, Çelik, Oğuzhan, Çil, Cem, Karaarslan, Osman, Doğan, Tolga, Yetim, Mücahit, Asoğlu, Ramazan, Çelik, Yunus, Kalkan, Sedat, Demirci, Erkan, Altuntaş, Emine, Taylan, Gökay, Küçük, Emrah, Küçüksu, Zafer, Aslan, Onur, Civan, Murat, Başaran, Özcan, Biteker, Murat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Society of Cardiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366408/
https://www.ncbi.nlm.nih.gov/pubmed/35435837
http://dx.doi.org/10.5152/AnatolJCardiol.2021.541
_version_ 1784765558201253888
author Memiç Sancar, Kadriye
Çelik, Oğuzhan
Çil, Cem
Karaarslan, Osman
Doğan, Tolga
Yetim, Mücahit
Asoğlu, Ramazan
Çelik, Yunus
Kalkan, Sedat
Demirci, Erkan
Altuntaş, Emine
Taylan, Gökay
Küçük, Emrah
Küçüksu, Zafer
Aslan, Onur
Civan, Murat
Başaran, Özcan
Biteker, Murat
author_facet Memiç Sancar, Kadriye
Çelik, Oğuzhan
Çil, Cem
Karaarslan, Osman
Doğan, Tolga
Yetim, Mücahit
Asoğlu, Ramazan
Çelik, Yunus
Kalkan, Sedat
Demirci, Erkan
Altuntaş, Emine
Taylan, Gökay
Küçük, Emrah
Küçüksu, Zafer
Aslan, Onur
Civan, Murat
Başaran, Özcan
Biteker, Murat
author_sort Memiç Sancar, Kadriye
collection PubMed
description BACKGROUND: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial has been the largest study ever conducted among patients in Turkey regarding aspirin treatment. In the subgroup analysis of the hypertensive group of the Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial, we aimed to evaluate the physicians’ adherence to current guidelines regarding their aspirin treatment preferences. METHODS: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial is a cross-sectional and multicenter study conducted among 5007 consecutive patients aged ≥18 years. The study population consisted of outpatients on aspirin treatment (80-300 mg). The patient data were obtained from 30 different cardiology clinics of 14 cities from all over Turkey. In this subgroup analysis, patients were divided into 2 groups: the hypertensive group (n = 3467, 69.3%) and the group without hypertension (n = 1540, 30.7%) according to the 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension. RESULTS: Aspirin use for primary prevention was higher in patients with hypertension compared to patients without hypertension [328 (21.3%); 1046 (30.2%); P < .001]. Treatment with a dose of 150 mg aspirin (n = 172, 5%) was mostly preferred by internists for hypertensive patients (n =226, 6.5%); however, a daily dose of 80-100 mg aspirin therapy (n = 1457, 94.6%) was mostly prescribed by cardiologists (n = 1347, 87.5%) for patients without hypertension. CONCLUSION: Aspirin was found to be used commonly among patients with hypertension for primary prevention despite the current European Society of Cardiology Arterial Hypertension Guideline not recommending aspirin for primary prevention in patients with hypertension.
format Online
Article
Text
id pubmed-9366408
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Society of Cardiology
record_format MEDLINE/PubMed
spelling pubmed-93664082022-08-18 An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey Memiç Sancar, Kadriye Çelik, Oğuzhan Çil, Cem Karaarslan, Osman Doğan, Tolga Yetim, Mücahit Asoğlu, Ramazan Çelik, Yunus Kalkan, Sedat Demirci, Erkan Altuntaş, Emine Taylan, Gökay Küçük, Emrah Küçüksu, Zafer Aslan, Onur Civan, Murat Başaran, Özcan Biteker, Murat Anatol J Cardiol Original Investigation BACKGROUND: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial has been the largest study ever conducted among patients in Turkey regarding aspirin treatment. In the subgroup analysis of the hypertensive group of the Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial, we aimed to evaluate the physicians’ adherence to current guidelines regarding their aspirin treatment preferences. METHODS: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial is a cross-sectional and multicenter study conducted among 5007 consecutive patients aged ≥18 years. The study population consisted of outpatients on aspirin treatment (80-300 mg). The patient data were obtained from 30 different cardiology clinics of 14 cities from all over Turkey. In this subgroup analysis, patients were divided into 2 groups: the hypertensive group (n = 3467, 69.3%) and the group without hypertension (n = 1540, 30.7%) according to the 2018 European Society of Cardiology/European Society of Hypertension Guidelines for the Management of Arterial Hypertension. RESULTS: Aspirin use for primary prevention was higher in patients with hypertension compared to patients without hypertension [328 (21.3%); 1046 (30.2%); P < .001]. Treatment with a dose of 150 mg aspirin (n = 172, 5%) was mostly preferred by internists for hypertensive patients (n =226, 6.5%); however, a daily dose of 80-100 mg aspirin therapy (n = 1457, 94.6%) was mostly prescribed by cardiologists (n = 1347, 87.5%) for patients without hypertension. CONCLUSION: Aspirin was found to be used commonly among patients with hypertension for primary prevention despite the current European Society of Cardiology Arterial Hypertension Guideline not recommending aspirin for primary prevention in patients with hypertension. Turkish Society of Cardiology 2022-04-01 /pmc/articles/PMC9366408/ /pubmed/35435837 http://dx.doi.org/10.5152/AnatolJCardiol.2021.541 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Investigation
Memiç Sancar, Kadriye
Çelik, Oğuzhan
Çil, Cem
Karaarslan, Osman
Doğan, Tolga
Yetim, Mücahit
Asoğlu, Ramazan
Çelik, Yunus
Kalkan, Sedat
Demirci, Erkan
Altuntaş, Emine
Taylan, Gökay
Küçük, Emrah
Küçüksu, Zafer
Aslan, Onur
Civan, Murat
Başaran, Özcan
Biteker, Murat
An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
title An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
title_full An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
title_fullStr An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
title_full_unstemmed An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
title_short An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
title_sort evaluation of aspirin treatment preferences of physicians in hypertensive patients in terms of current guidelines: a subgroup analysis of the assos trial in turkey
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366408/
https://www.ncbi.nlm.nih.gov/pubmed/35435837
http://dx.doi.org/10.5152/AnatolJCardiol.2021.541
work_keys_str_mv AT memicsancarkadriye anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT celikoguzhan anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT cilcem anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT karaarslanosman anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT dogantolga anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT yetimmucahit anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT asogluramazan anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT celikyunus anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT kalkansedat anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT demircierkan anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT altuntasemine anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT taylangokay anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT kucukemrah anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT kucuksuzafer anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT aslanonur anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT civanmurat anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT basaranozcan anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT bitekermurat anevaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT memicsancarkadriye evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT celikoguzhan evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT cilcem evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT karaarslanosman evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT dogantolga evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT yetimmucahit evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT asogluramazan evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT celikyunus evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT kalkansedat evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT demircierkan evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT altuntasemine evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT taylangokay evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT kucukemrah evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT kucuksuzafer evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT aslanonur evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT civanmurat evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT basaranozcan evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey
AT bitekermurat evaluationofaspirintreatmentpreferencesofphysiciansinhypertensivepatientsintermsofcurrentguidelinesasubgroupanalysisoftheassostrialinturkey